FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to a linker link, and can be used as a cross-linking agent for combining different antibodies or other biologically active agents into conjugates and constructing molecular structures with a specific combination of targeting and effector elements using chemical synthesis or recombinant technology.
EFFECT: disclosed are molecular structures with targeting and effector elements.
3 cl, 4 dwg, 72 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MOLECULAR STRUCTURES WITH TARGETING AND EFFECTOR ELEMENTS AND METHODS FOR USE THEREOF | 2016 |
|
RU2703952C2 |
| LINKER LINKS AND MOLECULAR STRUCTURES CONTAINING THEM | 2018 |
|
RU2752671C2 |
| COMPOSITE POLYPEPTIDE HAVING METAL-BINDING MOTIF AND MOLECULAR STRUCTURE CONTAINING THEREOF | 2020 |
|
RU2814475C2 |
| PHARMACEUTICAL STRUCTURES WITH INCREASED ALBUMIN BINDING AFFINITY | 2018 |
|
RU2753880C1 |
| SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION BY MEANS OF GLYCOENGINEERING | 2014 |
|
RU2711935C2 |
| LABELED CHIMERIC EFFECTOR MOLECULES AND RECEPTORS THEREOF | 2014 |
|
RU2729463C2 |
| CD3-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND THEIR APPLICATIONS | 2020 |
|
RU2808138C1 |
| METHOD FOR SELECTION AND PRODUCTION OF SELECTIVE AND MULTISPECIFIC THERAPEUTIC MOLECULES WITH SPECIFIED PROPERTIES, INCLUDING, AT LEAST TWO, DIFFERENT TARGET GROUPS, AND THEIR APPLICATIONS | 2013 |
|
RU2644263C2 |
| COVALENT DIANTIBODIES AND USE THEREOF | 2009 |
|
RU2593720C2 |
| HYPERGLYCOSYLATED BINDING POLYPEPTIDES | 2014 |
|
RU2708314C2 |
